Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BRD1 | O95696 | 1/20 | 0.32 |
| ▸ | PDE6D | O43924 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20821703 | 0.88 | L3MBTL1 (0.42) | KDM4EATML3MBTL1PTGER4CYP1A2 | |
| SCHEMBL16171601 | 0.88 | L3MBTL1 (0.44) | KDM4EATML3MBTL1PTGER4CYP1A2 | |
| SCHEMBL25972721 | 0.88 | CYP1A2 (0.38) | KDM4EATML3MBTL1BRD1CYP1A2 | |
| SCHEMBL15480134 | 0.87 | L3MBTL1 (0.47) | KDM4EATML3MBTL1PTGER4CYP1A2 | |
| SCHEMBL15480106 | 0.87 | L3MBTL1 (0.47) | KDM4EATML3MBTL1PTGER4CYP1A2 | |
| SCHEMBL20654752 | 0.86 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL24525981 | 0.86 | L3MBTL1 (0.37) | KDM4EATML3MBTL1PDE6DPTGER4 | |
| SCHEMBL24526011 | 0.86 | L3MBTL1 (0.37) | KDM4EATML3MBTL1PDE6DCYP1A2 | |
| SCHEMBL25972755 | 0.85 | L3MBTL1 (0.43) | KDM4EATML3MBTL1PDE6DPTGER4 | |
| SCHEMBL24526123 | 0.84 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PTGER4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250048-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-10 | — | — | US | disclosed |
| US-20230250048-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250048-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | NOS1, NOM1, NCF1 | KDM4E 1616/4885ATM 1439/4885L3MBTL1 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.